KIMS Hospitals Reports Strong Revenue Growth Amid Profit Dip in Q1 FY27

Krishna Institute of Medical Sciences Ltd (KIMS) reported significant operational revenue growth of 35.3% year-on-year, reaching ₹1,179.5 crore in the first quarter of FY27. Despite this top-line surge, the company's Profit After Tax (PAT) saw a substantial decrease of 56%, settling at ₹37.4 crore for the quarter.

Reader Takeaway: Strong revenue growth driven by volume and capacity expansion, but higher ramp-up costs pressure short-term profits.

What just happened

KIMS Hospitals announced its financial results for the first quarter of the fiscal year 2027 (Q1 FY27). Operating revenue increased by 35.3% to ₹1,179.5 crore, compared to ₹871.6 crore in Q1 FY26. EBITDA grew by 20.1% to ₹239.8 crore. However, PAT declined by 56.0% from ₹85.0 crore in Q1 FY26 to ₹37.4 crore in Q1 FY27.

Why this matters

The robust revenue growth indicates strong demand and successful expansion of services. However, the significant drop in PAT highlights the financial impact of the company's aggressive growth strategy, particularly the operational costs of new facilities in Kerala, Maharashtra, and Karnataka.

The backstory

KIMS Hospitals has been on an expansion drive, increasing its bed capacity to 7,459 beds. This includes recent additions of 787 beds in Kondapur and 208 in Palakkad. The company is actively working to bring new units to profitability, with several already achieving EBITDA-positive status.

What changes now

Investors will be closely watching the company's ability to manage the costs associated with its expansion and bring new units to profitability. The focus will be on improving occupancy rates and converting top-line growth into bottom-line performance in the coming quarters.

Risks to watch

• Profitability pressure from the high costs of new unit ramp-ups.
• Fluctuating occupancy rates across various geographies and facilities.

Peer comparison

While specific peer data for Q1 FY27 is not provided in the filing, KIMS's strategy of aggressive capacity expansion and volume growth is common among larger hospital chains in India aiming to capture market share.

Context metrics (time-bound)

In Q1 FY27, KIMS's bed capacity stood at 7,459. Inpatient (IP) volumes grew by 26.6% YoY, and Outpatient (OP) volumes grew by 28.5% YoY. The overall occupancy rate was 49.0%. Several new units achieved EBITDA-positive status during the quarter.

What to track next

Investors should monitor the company's progress in improving PAT margins, the ramp-up of new facilities, and overall occupancy rates across its network. The transition of more units to EBITDA-positive status and eventual net profit generation will be key indicators.